As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set ...

Marlborough, Massachusetts--(Newsfile Corp. - June 6, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...

Glioblastoma multiforme (GBM) is the most common type of primary brain tumor in adults and has a poor prognosis. Small interfering RNA (siRNA) can disrupt different mechanisms involved in the genesis ...

Abstract: Magnetic sensor arrays have been widely regarded as the practical implementations of current transducers, due to their ability to meet the demands for low power consumption and high accuracy ...

Third Person Shooters "Super Earth has been invaded": Helldivers 2 players failed their last Major Order, so now they have to fight to save their homeworld in the new Heart of Democracy update ...

Furthermore, PCR methods frequently exhibit compromised accuracy, precision, and robustness, which are attributed to matrix interference. Recently, LC/MS-based methodology has gained widespread ...